2Carter G, Lemoine NR. Antisense technology for cancer therapy: does it makes sense?[J]. Br J Cancer, 1993,67:869.
3Chiang MY, Chan H, Zounes MS, et al. Antisense oligonucleotides inhbit intercellular adhesion molecule 1 expression by two distinct mechanisms[J]. J Bio Chem,1991,266:18162.
4Norton JC, Piatyszek MA, Wright WE, et al. Inhbition of human telomerase activity by peptide nucletic acids[J]. Nature Biotech, 1996,14:615.
5Kanazawa Y, Ohkawa K, Veda K, et al. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells[J]. Biochem Biophys Res Commun, 1996,225(2):570.
6Zhu XL, Kumar R, Mandal M, et al. Cell cycle-dependent modulation of telomerase activity in tumor cells[J]. Proc Natl Acad Sci USA, 1996,93:6091.
7Holt SE, Wright WE, Shay JW, et al. Regulation of telomerase activity in immortal cell lines[J]. Mol Cell Biol, 1996,6:2932.
8Neilsen PE.A new target for gene therapeutics: telomerase[J]. Nature Biotech, 1996,14:580.
9Shang JW, Bacchetti S. A survey of telomerase activity in human cancer[J]. Eur J Cancer, 1997,33: 787.
10Kim NW. Clinical implications of telomerase in cancer[J]. Eur J Cancer, 1997,33(5):781.
